Bart Marescau

3.6k total citations
80 papers, 2.5k citations indexed

About

Bart Marescau is a scholar working on Cell Biology, Physiology and Clinical Biochemistry. According to data from OpenAlex, Bart Marescau has authored 80 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cell Biology, 25 papers in Physiology and 18 papers in Clinical Biochemistry. Recurrent topics in Bart Marescau's work include Muscle metabolism and nutrition (24 papers), Metabolism and Genetic Disorders (18 papers) and Neuroscience and Neuropharmacology Research (14 papers). Bart Marescau is often cited by papers focused on Muscle metabolism and nutrition (24 papers), Metabolism and Genetic Disorders (18 papers) and Neuroscience and Neuropharmacology Research (14 papers). Bart Marescau collaborates with scholars based in Belgium, Netherlands and United States. Bart Marescau's co-authors include Peter Paul De Deyn, Rudi D’Hooge, Peter Paul De Deyn, A. Löwenthal, Olivier Levillain, Yin‐Quan Pei, Mumna Al Banchaabouchi, Rudi D’Hooge, W. Lornoy and I. Becaus and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and The Journal of Physiology.

In The Last Decade

Bart Marescau

80 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bart Marescau Belgium 32 623 605 574 566 459 80 2.5k
Nigishi Hotta Japan 28 868 1.4× 547 0.9× 461 0.8× 693 1.2× 410 0.9× 100 3.3k
Nobuo Sakamoto Japan 25 709 1.1× 331 0.5× 308 0.5× 649 1.1× 165 0.4× 153 2.9k
Nathan L. Alderson United States 25 1.1k 1.8× 464 0.8× 1.2k 2.1× 1.1k 2.0× 253 0.6× 39 4.0k
C. Bachmann Switzerland 37 871 1.4× 549 0.9× 1.9k 3.4× 1.6k 2.8× 119 0.3× 145 4.1k
Marjorie Dunlop Australia 28 407 0.7× 403 0.7× 346 0.6× 967 1.7× 191 0.4× 96 2.6k
David V. Godin Canada 30 611 1.0× 133 0.2× 320 0.6× 953 1.7× 107 0.2× 70 3.2k
Sookja Kim Chung Hong Kong 30 651 1.0× 1.0k 1.7× 480 0.8× 1.3k 2.3× 65 0.1× 75 3.2k
Raffaella Mastrocola Italy 36 821 1.3× 198 0.3× 435 0.8× 1.4k 2.4× 170 0.4× 78 3.5k
Chihiro Yabe‐Nishimura Japan 37 1.3k 2.0× 715 1.2× 425 0.7× 1.6k 2.9× 80 0.2× 91 4.1k
Atsuo Goto Japan 35 760 1.2× 106 0.2× 387 0.7× 1.8k 3.3× 756 1.6× 124 4.2k

Countries citing papers authored by Bart Marescau

Since Specialization
Citations

This map shows the geographic impact of Bart Marescau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Marescau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Marescau more than expected).

Fields of papers citing papers by Bart Marescau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart Marescau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Marescau. The network helps show where Bart Marescau may publish in the future.

Co-authorship network of co-authors of Bart Marescau

This figure shows the co-authorship network connecting the top 25 collaborators of Bart Marescau. A scholar is included among the top collaborators of Bart Marescau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart Marescau. Bart Marescau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhargava, Ragini, Nora Rozengurt, Bart Marescau, et al.. (2013). AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse. Gene Therapy. 20(8). 785–796. 31 indexed citations
2.
Choe, Chi‐un, Christine Nabuurs, Malte Stockebrand, et al.. (2012). l-arginine:glycine amidinotransferase deficiency protects from metabolic syndrome. Human Molecular Genetics. 22(1). 110–123. 74 indexed citations
3.
Eloot, Sunny, An Torremans, Rita De Smet, et al.. (2007). Complex Compartmental Behavior of Small Water-Soluble Uremic Retention Solutes: Evaluation by Direct Measurements in Plasma and Erythrocytes. American Journal of Kidney Diseases. 50(2). 279–288. 62 indexed citations
4.
Taes, Youri, Bart Marescau, An S. De Vriese, et al.. (2007). Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status. Nephrology Dialysis Transplantation. 23(4). 1330–1335. 23 indexed citations
5.
Torremans, An, Bart Marescau, Debby Van Dam, et al.. (2005). GSA: behavioral, histological, electrophysiological and neurochemical effects. Physiology & Behavior. 84(2). 251–264. 14 indexed citations
6.
Dam, Debby Van, Bart Marescau, Sebastiaan Engelborghs, et al.. (2005). Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models. Neurochemistry International. 46(5). 409–422. 34 indexed citations
7.
Eloot, Sunny, An Torremans, Rita De Smet, et al.. (2005). Kinetic behavior of urea is different from that of other water-soluble compounds: The case of the guanidino compounds. Kidney International. 67(4). 1566–1575. 88 indexed citations
8.
Eloot, Sunny, Rita De Smet, Dirk De Wachter, et al.. (2004). Inadequate representativity of urea for the kinetics of other uremic solutes: the case of the guanidines R. De Smet, A. Torremans, D. De Wachter, B. Marescau, P.P. De Deyn, P. Verdonck, R. Vanholder. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
9.
Engelborghs, Sebastiaan, Bart Marescau, & Peter Paul De Deyn. (2003). Amino Acids and Biogenic Amines in Cerebrospinal Fluid of Patients with Parkinson's Disease. Neurochemical Research. 28(8). 1145–1150. 70 indexed citations
10.
D’Hooge, Rudi, et al.. (2003). Involvement of voltage- and ligand-gated Ca2+ channels in the neuroexcitatory and synergistic effects of putative uremic neurotoxins. Kidney International. 63(5). 1764–1775. 47 indexed citations
11.
Jonge, Wouter J. de, M.M. Hallemeesch, Karin L. Kwikkers, et al.. (2002). Overexpression of arginase I in enterocytes of transgenic mice elicits a selective arginine deficiency and affects skin, muscle, and lymphoid development,,. American Journal of Clinical Nutrition. 76(1). 128–140. 39 indexed citations
12.
Deyn, Peter Paul De, et al.. (2001). Endogenous guanidino compounds as uremic neurotoxins. Kidney International. 59. S77–S83. 107 indexed citations
13.
Banchaabouchi, Mumna Al, Bart Marescau, Rudi D’Hooge, & Peter Paul De Deyn. (2001). The effect of high protein diet on urea and guanidino compound levels in renal insufficient mice. Amino Acids. 21(4). 401–415. 2 indexed citations
14.
Levillain, Olivier, et al.. (2001). Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study. Pflügers Archiv - European Journal of Physiology. 442(4). 558–569. 14 indexed citations
15.
Banchaabouchi, Mumna Al, Rudi D’Hooge, Bart Marescau, & Peter Paul De Deyn. (1999). Behavioural Deficits During the Acute Phase of Mild Renal Failure in Mice. Metabolic Brain Disease. 14(3). 173–187. 11 indexed citations
16.
Matthys, K. E., Cor E. Van Hove, Philippe G. Jorens, et al.. (1996). Dual effects of oxidized low-density lipoprotein on ommune-stimulated nitric oxide and prostaglandin release in macrophages. European Journal of Pharmacology. 298(1). 97–103. 9 indexed citations
17.
Marescau, Bart, et al.. (1995). Guanidino compounds in serum and urine of cirrhotic patients. Metabolism. 44(5). 584–588. 31 indexed citations
18.
Marescau, Bart, et al.. (1992). Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals. Metabolism. 41(5). 526–532. 124 indexed citations
19.
D’Hooge, Rudi, Yin‐Quan Pei, Bart Marescau, & Peter Paul De Deyn. (1992). Behavioral toxicity of guanidinosuccinic acid in adult and young mice. Toxicology Letters. 64-65. 773–777. 6 indexed citations
20.
Deyn, Peter Paul De, et al.. (1987). Serum Guanidino Compound Levels and the Influence of a Single Hemodialysis in Uremic Patients Undergoing Maintenance Hemodialysis. ˜The œNephron journals/Nephron journals. 45(4). 291–295. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nigishi Hotta Breakdown of academic impact, for papers by Nobuo Sakamoto Breakdown of academic impact, for papers by Nathan L. Alderson Breakdown of academic impact, for papers by C. Bachmann Breakdown of academic impact, for papers by Marjorie Dunlop Breakdown of academic impact, for papers by David V. Godin Breakdown of academic impact, for papers by Sookja Kim Chung Breakdown of academic impact, for papers by Raffaella Mastrocola Breakdown of academic impact, for papers by Chihiro Yabe‐Nishimura Breakdown of academic impact, for papers by Atsuo Goto
Rankless by CCL
2026